Randhawa 2016
Randhawa 2016
Randhawa 2016
whiplash injuries.15 One systematic review suggests that the more of the following signs or symptoms: pain, abnormal
incidence of TMD is higher in individuals with whiplash joint sounds, limited jaw movement, joint tenderness, and
injuries (range, 4% to 35%) compared with individuals muscle tenderness.3
without a history of such injuries (range, 4.7% to 7%).16 In
Saskatchewan, Canada, the incidence of self-reported Interventions
reduced or painful jaw movement was 15.8% in individuals We included any noninvasive intervention. These
who reported whiplash-associated disorders (WAD) versus include passive physical modalities, exercise, occlusal devi-
4.7% in those without WAD.9 In the Saskatchewan cohort, ces, manual therapy, soft-tissue therapy, acupuncture,
reduced or painful jaw movement was associated with psychological interventions, and education. We excluded
female sex, age less than 50 years, having hit one’s head in pharmacological interventions and invasive interventions
the collision, and postinjury symptoms of difficulty swal- (eg, injections, surgical procedures).
lowing, ringing in the ears, dizziness or unsteadiness, and
more intense neck pain.9 The management of TMD com- Comparison Groups
monly involves noninvasive interventions such as acu- We included studies that compared noninvasive
puncture, physical therapy, passive modalities, orthodontic interventions to other interventions, placebo/sham inter-
therapy, and occlusal appliances.1 ventions, or no intervention.
We identified 9 systematic reviews that evaluated the
effectiveness of noninvasive interventions for TMD.17–25 Outcomes
However, the effectiveness and cost-effectiveness of most Eligible studies included at least one of the following
interventions remains unclear19,22,24; this may be partially outcomes: (1) pain intensity; (2) functional recovery (eg,
attributed to the methodology used in these systematic disability, return to work); (3) self-rated recovery: (4)
reviews. Most reviews included results from studies with health-related quality of life; (5) psychological outcomes
significant biases (eg, no randomization, no intention-to- such as depression; or (6) adverse effects. Eligible economic
treat analysis, no allocation concealment, differences in evaluations reported health outcomes expressed as quality-
baseline characteristics)17–19,21–25 and small sample sizes.17–25 adjusted life-years, the health economic outcome measure.
Moreover, several systematic reviews only considered stat-
istical significance, and did not assess the clinical significance Study Characteristics
of results.18,20,23,25 Finally, we did not identify any system- Eligible studies met the following criteria: (1) English
atic reviews on the cost-effectiveness of noninvasive inter- language; (2) published in a peer-reviewed journal; (3) study
ventions for TMD. designs including: randomized controlled trials (RCTs),
The objective of our review was to investigate the cohort studies, and case-control studies; and (4) an incep-
effectiveness and cost-effectiveness of noninvasive inter- tion cohort of 30 individuals per treatment arm for RCTs
ventions compared with other interventions, placebo/sham or 100 patients per exposed group for cohort studies.
interventions, or no intervention in improving self-rated Studies were excluded if the following criteria were met: (1)
recovery, functional recovery, or clinical outcomes in adults letters, editorials, commentaries, unpublished manuscripts,
and children with TMD. dissertations, government reports, books and book chap-
ters, conference proceedings, meeting abstracts, lectures
METHODS and addresses, consensus development statements, guide-
line statements; (2) study designs including: clinical practice
Registration guidelines, cross-sectional studies, case reports, case series,
This review protocol was registered with the Interna- guidelines, qualitative studies, nonsystematic and system-
tional Prospective Register of Systematic Reviews (PROS- atic reviews (with or without meta-analyses), biomechanical
PERO) on October 7, 2013 (CRD42013005910) for studies, laboratory studies, studies not reporting on
effectiveness and March 14, 2014 (CRD42014009041) for methodology; or (3) cadaveric or animal studies.
cost-effectiveness. Eligible cost-effectiveness studies were full economic
evaluations of any noninvasive intervention for treating
Eligibility Criteria TMD in children and adults. Full economic evaluations
were defined as comparisons that jointly analyzed costs
Population (resource use) and consequences (health outcomes), and
Our review included studies of adults and/or children expressed cost-effectiveness with the incremental cost-
diagnosed with TMD. We excluded studies of patients with effectiveness ratio or incremental net-benefit statistic.
severe injuries, which include but are not limited to grade
III sprains/strains, dislocations, fractures, ruptures, and Information Sources
osteonecrosis. We developed search strategies in consultation with a
We defined TMD as a group of conditions that affect health sciences librarian (Appendix 1 and 2, Supplemental
the masticatory muscles, the TMJ, and surrounding struc- Digital Content 1, http://links.lww.com/CJP/A178). The
tures, and include sprain and strain injuries to this ana- search strategies were reviewed by a second librarian to
tomic region.3 Sprains may involve supporting ligaments of ensure completeness and accuracy using the Peer Review of
the TMJ, including the collateral ligament, capsular liga- Electronic Search Strategies checklist.26 We systematically
ment, and temporomandibular ligament. Sprains may also searched the following electronic databases for effectiveness
involve ligaments adjacent to the TMJ, including the evidence from January 1, 1990 to November 4, 2014:
sphenomandibular ligament and stylomandibular ligament. MEDLINE, EMBASE, CINAHL, PsychINFO, and
Strains may involve supporting muscles of the TMJ, Cochrane Central Register of Controlled Trials. We sys-
including the masseter, medial and lateral pterygoid, tem- tematically searched for cost-effectiveness evidence in the
poralis, and digastrics. TMD presents clinically with one or following databases from January 1, 1990 to January 7,
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.clinicalpain.com | 261
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Randhawa et al Clin J Pain Volume 32, Number 3, March 2016
262 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Clin J Pain Volume 32, Number 3, March 2016 Effectiveness of Noninvasive Interventions for TMD
TABLE 1. Summary of Assessment of Risk of Bias for Accepted Studies Based on SIGN Criteria
Results
Similarity Similarity Outcome Comparable
Research Randomiz- Conceal- Blind- at Between Measure- Drop- Intention- Between
References Question ation ment ing Baseline Arms ment Out (%)* to-Treat Sites
Dworkin et al35 Y CS N Y Y CS Y Posttreatment: Y CS
CC: 12%
UT:16%
12 mo:
CC: 5%
UT: 12%
Dworkin et al36 Y CS N CS N N Y SC: 21.3% Y NA
UT: 19%
Gatchel et al37 Y CS N N N N Y Overall: 3/ Y NA
101 = 2.97%
Drop- out rate
for each group
unknown
Kalamir et al38 Y Y Y Y CS CS Y 6 wk: Y NA
IMT: none
IMTESC: 0%
Control: 0%
6 mo:
IMT: 0%
IMTESC: 0%
Control: 0%
1 y:
Control: 3%
IMT: 0%
IMTESC: 0%
Niemela et al39 Y Y N Y Y CS Y 1 mo: N NA
Splint: 0%
Control: 10%
Turk et al40 Y CS N Y N CS Y 7 wk: N NA
IA: 6.67%; BF/
SM: 0%
6 mo:
IA: 10.7% BF/
SM: 13.3%
Turner Y Y Y Y Y N Y Postintervention: Y NA
and The mean
colleagues41,42 percent of
electronic
interviews
completed was
90% in both
the CBT and
SCM groups
(for total
sample,
SD = 9%)
8 wk:
CBT: 11%
SCM: 9%
6 mo:
CBT: 14%
SCM: 9%
12 mo:
CBT: 14%
SCM: 11%
*Percent drop-out includes drop-outs and loss to follow-up.
BF indicates biofeedback; CBT, cognitive-behavioral therapy; CC, comprehensive care; CS, can’t say; IA, intraoral appliance; IMT, intraoral myofascial
therapy; IMTESC, intraoral myofascial therapy, education, and stretching; N, no; NA, not applicable; SC, self-care; SCM, self-care management; SM, stress
management; UT, usual treatment; Y, yes.
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.clinicalpain.com | 263
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Randhawa et al Clin J Pain Volume 32, Number 3, March 2016
described in 5 studies35–37,39–40 and randomization was not usual treatment included multimodal care prescribed by the
adequately described in 4 RCTs.35–37,40 Many studies (4/7) attending dentists that included a combination of: (1) phys-
did not describe cointerventions35,38–40 or reported differ- iotherapy; (2) patient education; (3) medication; and (4)
ences in cointervention between groups (3/7).36,37,41–42 Two intraoral flat-plane occlusal appliances. The authors reported
studies did not report an intention-to-treat analysis.39,40 statistically significant differences between groups immedi-
The 23 studies with a high risk of bias had important ately postintervention for pain intensity, ability to control
methodological limitations. The most common limitations pain, and satisfaction and helpfulness of treatment favouring
related to: (1) randomization method (16/23); (2) conceal- the CBT group. The clinical importance of these outcomes is
ment of treatment allocation (18/23); (3) differences in unknown. There were no differences between groups at the
baseline characteristics (19/23); and (4) report of coin- 6- and 12-month follow-ups.
terventions (19/23). Furthermore, several studies with a
high risk of bias had >20% attrition (7/23) or did not Self-Care Management
conduct or report having performed an intention-to-treat Evidence from 1 RCT suggests that structured self-
analysis (18/23). We contacted the authors of 7 studies to care management may be more beneficial than usual
obtain clarification about their methodology37,39,40,42,52–54; treatment for the management of persistent TMD.36
6 authors responded to our queries.35,39–41,53–54 Dworkin and colleagues randomized participants to: (1)
structured self-care management; or (2) usual treatment
Summary of Evidence (Table 2).48 Structured self-care management was provided
We did not find studies with low risk of bias that by a dental hygienist and involved 3 sessions over 2 and a
informed the management of recent onset (< 3 mo) of half months. The structured self-care management empha-
TMD. sized education, guided reading with structured feedback,
relaxation and stress management training, self-monitoring
Persistent TMD (Z3 mo)
of signs and symptoms, development of a “Personal TMD
Cognitive-Behavioral Therapy Self-care Plan,” supervised practice and reinforcement of
Evidence from 2 RCTs suggests that CBT may benefit dentist-prescribed self-care treatments, and maintenance
patients with persistent TMD.35,41,42 In her trial, Turner and relapse prevention. The usual care included multimodal
and colleagues randomized participants to 4 sessions (over care prescribed by a dentist and included: (1) physi-
8 wk) of CBT by a clinical psychologist or self-management otherapy; (2) education; (3) medication; and (4) intraoral
by a patient educator41,42 (Table 2). CBT included pro- flat-plane occlusal appliances. There were statistically sig-
gressive relaxation and abdominal/diaphragmatic breathing nificant between-group differences at 12 months for pain
techniques, a relaxation audiotape, discussion regarding intensity, activity interference, depression and somatisation,
fear-avoidance, the identification and challenging of neg- helpfulness of treatment, coping with pain, level of TMD
ative thoughts in response to pain, relapse prevention, ways knowledge, and number of sites painful to palpation
to maintain gains, and methods to deal with setbacks. favouring structured self-care management.
Participants randomized to CBT also received a weekly
personal TMD health care plan. The self-care management Myofascial Therapy
group received information about TMD and a manual on Evidence from 1 RCT suggests that intraoral myo-
general health care. Both groups received usual treatment fascial therapy may be more effective than wait listing in
from a dentist (jaw posture monitoring and correction; reducing pain and improving jaw opening in patients with
advice heat/cold to facial areas; diet modification; medi- persistent TMD.38 However, the addition of structured
cation; jaw-stretching exercises, and occlusal device if education and TMD stretching to intraoral myofascial
indicated). Compared with those who received the self-care therapy does not provide additional benefits. In their trial,
management intervention, participants randomized to CBT Kalamir et al38 randomized participants to: (1) intraoral
were 4 times more likely to report no interference with their myofascial therapy; (2) intraoral myofascial therapy with
activities at the 1-year follow-up (odds ratio [OR] = 4.2; structured education and TMD stretching; or (3) wait list
95% CI, 1.7-10.2). Similarly, those in the CBT group were (Table 2). The intraoral myofascial therapy included: (1)
more likely to report low to moderate depressive symptoms intraoral temporalis release; (2) intraoral medial and lateral
(OR = 3.8; 95% CI, 1.2-12.0). The differences in mean pterygoid (origin) technique; and (3) intraoral sphenopa-
change between groups for pain intensity (Graded Chronic latine ganglion technique twice a week for 5 weeks. Par-
Pain Scale) were statistically significant but were not clin- ticipants who received intraoral myofascial therapy with
ically important. Finally, the CBT group demonstrated structured education and TMD stretching were instructed
statistically significant improvement in masticatory and on chewing technique and relaxation stretching. They also
nonmasticatory disability, but the clinical importance of attended short lectures on basic TMJ anatomy, bio-
this result is not known. mechanics, disk displacement and dysfunction, and the role
In the second RCT, Dworkin and colleagues random- of psychoemotional factors in TMD. At the 6-month fol-
ized participants to: (1) CBT combined with usual treatment; low-up, participants in the intraoral myofascial therapy
or (2) usual treatment alone (Table 2). CBT was delivered by group reported greater improvement in jaw pain at rest
clinical psychologists and involved 6 visits and 3 phone calls (mean difference: 2.59/10 [95% CI, 0.69-4.49]); jaw pain
over 6 weeks. The CBT emphasized patient education and upon maximal active opening (mean difference 2.53/10
self-care, the identification and modification of maladaptive [95% CI, 2.23-2.84]); and jaw pain upon clenching (mean
thought patterns related to pain, training in relaxation and difference: 3.66/10 [95% CI, 3.33-3.99]). Moreover, the
other pain management coping skills, and discussion of intraoral myofascial therapy group had greater improve-
relapse prevention and long-term maintenance of gains ment in jaw opening (Table 2). Similarly, participants who
achieved in treatment. Furthermore, modules were included received the myofascial therapy with structured education
to address somatization and depression when present. The and TMD stretching intervention had statistically and
264 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Clin J Pain Volume 32, Number 3, March 2016 Effectiveness of Noninvasive Interventions for TMD
TABLE 2. Evidence Table for Accepted Randomized Controlled Trials Assessing the Effectiveness of Noninvasive Interventions for TMD
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
Dworkin et al35 Patients (18- Comprehensive UT by attending Postintervention Characteristic Difference in
70 y) referred care (CC): dentist: (1) and 6, 12 mo pain intensity mean change
to the CBT by physiotherapy (RDC/TMD from baseline
Orofacial Pain clinical (passive and axis II (CC UT):
Clinics in the psychologist (6 active jaw measures 0- Characteristic
Department of visits + 3 range-of- 10); pain- pain intensity
Oral Medicine, phone calls/ motion and related activity (0-10)*w
University of 16 wk) and stretching interference Postintervention:
Washington UT. CBT exercises and score (RDC/ 1.4
School of included application of TMD axis II 12 mo: 0.4
Dentistry. education, heat or cold measures 0- Statistically
Case definition: identification, packs); (2) 10); depression significant
(1) self-report and patient and differences
of facial ache modification education somatization postinterven-
or pain in the of maladaptive (parafunc- scales (SCL- tion favouring
muscles of thought tional oral 90); ability to CC (P = 0.02).
mastication, patterns behaviors, control pain Pain-related
the TMJ, or related to diet, nature of (0-6); process activity
the region in pain, the condition, of care ratings interference
front of the relaxation, and rationale (0-10); vertical (0-10)*w
ear or inside and other pain for treatment); range of jaw Postintervention:
the ear; (2) coping skills, (3) motion (RDC/ 1.2
interference of and discussion medications TMD axis I No statistically
daily activities of relapse (analgesics, measures); significant
(RDC/TMD prevention NSAIDs, number of differences.
axis II GCP and long-term muscle sites of painful Depression and
score of II maintenance relaxants, palpation somatisation
high, III, or of gains antidepres- (RDC/TMD (SCL-90)
IV). (n = 117) achieved in sants); and (4) axis I No statistically
treatment. intraoral flat- measures); significant
Somatization plan occlusal axis I differences.
and depression appliances. No diagnoses. Ability to
were limitations on Adverse effects. control pain
addressed number of (0-6)*w
when present visits (n = 58). Postintervention:
(n = 59). 1.0
Statistically
significant
between-group
differences
postinterven-
tion favouring
CC
(P < 0.001).
Process of care
ratings
(satisfaction
and
helpfulness of
treatment; 0-
10)
Statistically
significant
between-group
differences
postinterven-
tion for
helpfulness of
treatment
favouring CC
(P = 0.03).
Vertical range of
jaw motion
(Continued )
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.clinicalpain.com | 265
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Randhawa et al Clin J Pain Volume 32, Number 3, March 2016
TABLE 2. (continued)
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
(mm)
No statistically
significant
differences.
Number of sites
painful to
palpation
Extraoral
muscles: 0.3
(95% CI,
1.5 to 0.9)
Intraoral
muscles: 0.2
(95% CI,
0.1 to 0.5)
TMJ: 0.4
(95% CI,
0.7 to 0.1)
Axis I diagnosis
No statistically
significant
differences.
Adverse effects
None.
Dworkin et al36 Patients (18- SCM by dental UT (no Postintervention Characteristic Difference in
70 y) referred hygienists (3 limitation on and 6, 12 mo pain intensity mean change
to the sessions/ number of (RDC/TMD from baseline
Orofacial Pain 2.5 mo): visits/2.5 mo): axis II (SCMUT):
Clinics in the education and noninvasive measures 0- Characteristic
Department of self-care for treatments: (1) 10); pain- pain intensity
Oral Medicine, TMD, physiotherapy related activity (0-10)
University of incorporating (passive and interference Statistically
Washington CBT methods. active jaw score (RDC/ significant
School of SC range-of- TMD axis II between-group
Dentistry. emphasized motion and measures 0- differences
Case definition: education, stretching 10); depression reported at
(1) self-report guided reading exercises and and 12 mo
of facial ache with application of somatization favouring
or pain in the structured heat or cold scales (SCL- SCM
muscles of feedback, packs); (2) 90); process of (P = 0.036).
mastication, relaxation and patient care ratings (0- Pain-related
the TMJ, or SM training, education; (3) 10); vertical activity
the region in self- medications range of jaw interference
front of the monitoring of (analgesics, motion (RDC/ (0-10)
ear or inside signs and muscle TMD axis I Statistically
the ear; (2) symptoms, relaxants, measures); significant
interference of development antidepres- number of between-group
daily activities of a “personal sants); and (4) sites of painful differences
(RDC/TMD TMD self-care intraoral flat- palpation reported at
axis II GCP plan,” plan occlusal (RDC/TMD 12 mo
score of 0, I, supervised appliances axis I favouring
or II-low practice, and (n = 63). measures). SCM
(n = 124). reinforcement Adverse events. (P = 0.01).
of dentist- Depression and
prescribed SC somatisation
treatments, (SCL-90)
maintenance, Statistically
and relapse significant
prevention between-group
(n = 61). differences for
somatization
at 12 mo
favouring
(Continued )
266 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Clin J Pain Volume 32, Number 3, March 2016 Effectiveness of Noninvasive Interventions for TMD
TABLE 2. (continued)
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
SCM
(P = 0.002).
Process of care
ratings
(satisfaction
and
helpfulness of
treatment; 0-
10)
Statistically
significant
between-group
differences at
12 mo for
helpfulness of
treatment
(P = 0.0002);
helpfulness in
overall coping
with TMD
pain
(P < 0.0001);
level of
knowledge
about TMD
(P < 0.0001);
and treatment
satisfaction
(P = 0.280)
favouring SC.
Vertical range of
jaw motion
(mm)
No statistically
significant
differences.
Number of sites
painful to
palpation*w
Extraoral
muscles: 1.0
Statistically
significant
differences
between
groups at
12 mo
favouring SC
(P = 0.007)
Adverse events
None.
Gatchel at al37 Adults (18-70 y) EI: CBT and Nonintervention 1y Primary: Difference in
recruited from biofeedback group (NI) characteristic mean change
referrals to a (BF) provided (n = 45). pain intensity from baseline
university by clinical (CPI). (EI–NI):
TMD clinical psychology Secondary: ways CPI: 12.39 (95%
research research of coping CI, 8.08-16.70)
program, personnel (WOC): blame Ways of Coping
fliers, and (6 1 h self, wishful Blame Self: 2.13
newspaper sessions). thinking, (95% CI, 0.95-
advertise- CBT: avoidance. 3.31)
ments, in education Depressive Wishful
Texas. mind-body symptom thinking: 0.16
(Continued )
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.clinicalpain.com | 267
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Randhawa et al Clin J Pain Volume 32, Number 3, March 2016
TABLE 2. (continued)
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
Case definition: relationship (BDI), (95% CI,
acute jaw or emphasizing affective 0.82 to 1.14)
facial pain stress, disorder, Avoidance: 0.82
<6 mo; relaxation anxiety (95% CI, 0.03-
myofascial training, disorder, 1.61)
pain based on distraction somatoform Problem focused:
axis I-group and pleasant disorder, 1.19 (95%
1a of RDC activity substance CI, 2.27 to
form, and scheduling, abuse, pain 0.11)
response to cognitive disorder. Seeks social
RDC history restructuring, support:
question: self- 1.83 (95%
“Have you instructional CI, 3.13 to
had pain in the training. 0.53)
face, jaw, BF: EMG and BDI (Mann-
temple, in temperature Whitney):
front of the biofeedback P = 0.03
ear, or in the units. Odds ratio (95%
ear in the last Work books CI)( NI vs.
month” with reading EI):
(n = 101). assignments Affective
and disorder: 2.70
homework to (0.91-7.97)
complete Anxiety
between disorder: 7.18
sessions (1.90-27.13)
(n = 56). Somatoform
disorder: 12.50
(4.44-35.22)
Pain disorder:
9.00 (3.46-
23.44)
Kalamir et al38 Patients (18- IMT (2 times/wk Wait list (WL) Postinterven- Primary: jaw Difference in
50 y) recruited for 5 wk): (1) (n = 31). tion, 6 and pain at rest mean change
from referrals intraoral 12 mo (11-point from
from dental temporalis scale), jaw baseline(IMT-
clinics in release; (2) pain upon WL)*:
Australia in intraoral maximal Pain at rest
2006-2007. medial and active opening Postintervention:
Case definition: lateral (11-point 2.65 (95% CI,
myogenous pterygoid scale), jaw 0.74-4.56)
TMD: daily technique; and pain upon 6 mo: 2.59 (95%
periauricular (3) intraoral clenching (11- CI, 0.69-4.49)
pain with or sphenopala- point scale). 1 y: 1.66 (95%
without joint tine ganglion Secondary: CI, 0.03 to
sounds technique opening range 3.35)
(Z3 mo); jaw (n = 31). of motion Pain upon
pain Z3/10 IMTES (12 (vernier maximal
for pain at visits/6 wk): callipers; mm). opening
rest, on education: Adverse events. Postintervention:
maximal short lectures 2.23 (95% CI,
opening, and on basic TMJ 1.93-2.54)
pain on anatomy, 6 mo: 2.53 (95%
clenching biomechanics, CI, 2.23-2.84)
(n = 93). disk 1 y: 1.47 (95%
displacement CI, 1.17-1.78)
and Pain upon
dysfunction, clenching
the role of Postintervention:
psychoemo- 3.55 (95% CI,
tional factors 3.21-3.88)
in TMD. 6 mo: 3.66 (95%
TMD stretching: CI, 3.33-3.99)
(Continued )
268 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Clin J Pain Volume 32, Number 3, March 2016 Effectiveness of Noninvasive Interventions for TMD
TABLE 2. (continued)
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
mandibular 1 y: 2.86 (95%
home CI, 2.53-3.19)
stretching Opening range of
including motion:
mandibular Postintervention:
body-condylar 5.16 (95% CI,
cross-pressure 3.49-6.83)
chewing 6 mo: 4.64 (95%
technique and CI, 2.97-6.32)
postisometric 1 y: 4.93 (95%
relaxation CI, 3.23-6.63)
stretches Difference in
(twice a day) mean change
(n = 31). from baseline
(IMTES W-
L)*:
Jaw pain at rest
Postintervention:
2.0 (95% CI,
0.03 to 4.03)
6 mo: 2.30 (95%
CI, 0.18-4.41)
1 y: 3.54 (95%
CI, 1.07-6.02)
Pain upon
maximal
opening
Postintervention:
2.15 (95% CI,
1.85-2.46)
6 mo: 2.31 (95%
CI, 2.01-2.61)
1 y: 3.75 (95%
CI, 3.45-4.05)
Pain upon
clenching
Postintervention:
2.42 (95% CI,
2.09-2.75)
6 mo: 2.84 (95%
CI, 2.51-3.16)
1 y: 3.73 (95%
CI, 3.40-4.05)
Opening range of
motion
Postintervention:
4.52 (95% CI,
2.72-6.31)
6 mo: 6.52 (95%
CI, 4.72-8.31)
1 y: 8.61 (95%
CI, 6.78-10.44)
Difference in
mean change
from baseline
(IMTES-
IMT)*:
Pain at rest
Postintervention:
0.65 (95%
CI, 3.16 to
1.86)
(Continued )
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.clinicalpain.com | 269
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Randhawa et al Clin J Pain Volume 32, Number 3, March 2016
TABLE 2. (continued)
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
6 mo: 0.30
(95% CI,
2.87 to 2.27)
1 y: 1.88 (95%
CI, 0.85 to
4.61)
Jaw pain upon
maximal
opening
Post: 0.65
(95% CI,
0.95 to
0.35)
6 mo: 0.22
(95% CI,
0.52 to 0.08)
1 y: 2.27 (95%
CI, 1.97 to
2.57)
Jaw pain upon
clenching
Postintervention:
1.12 (95%
CI, 1.45 to
0.80)
6 mo: 0.83
(95% CI,
1.15 to
0.50)
1 y: 0.86 (95%
CI, 0.54 to
1.19)
Opening range of
motion:
Post: 0.65
(95% CI,
2.26 to 0.97)
6 mo: 1.87 (95%
CI, 0.27-3.48)
1 y: 3.68 (95%
CI, 2.08-5.28)
No adverse
events
reported.
Niemela et al39 Patients (Z20 y) Occlusal device Structured 1 mo Pain intensity Difference in
referred to the (heat-cured masticatory (VAS 0-10), mean change
Oral and acrylic) and exercises active from baseline
Maxillofacial structured (same as maximal (Occlusal
Department, masticatory intervention opening (mm), deviceexer-
Oulu exercises group) and laterotrusion cise)
University (active mouth jaw stretching movement Pain intensity:
Hospital, openings, (n = 41). (left and right) 1 mo: 0.99
Finland in laterotrusive (mm), (95% CI,
2008-2009. movements, protrusion 2.21 to 0.22)
Case definition: and protrusive movement No statistically
diagnosis of movements) (mm), number significant
TMD and jaw of painful differences in
according to stretching muscle sites, laterotrustion
Research (n = 39). TMJ pain on movement,
Diagnostic palpation (% protrusion,
Criteria RDC/ of patients). active
TMD Adverse effects. maximal
(n = 80). opening, and
(Continued )
270 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Clin J Pain Volume 32, Number 3, March 2016 Effectiveness of Noninvasive Interventions for TMD
TABLE 2. (continued)
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
TMJ pain on
palpation.
Adverse events:
Pain on TMJ
palpation
increased
significantly in
the occlusal
device group,
which may
indicate a
negative effect
of the occlusal
device on
distinct TMJ
findings.
Turk et al40 Patients (18- BF/SM: 1 h/wk/ Wait list Postintervention Pain (PSS 0-10); Difference in
55 y) referred 6 wk by (n = 20). and 6 mo muscle mean change
to an psychologist palpation pain from baseline
outpatient BF: (1) index (PPI); (BF/SMIA):
TMD clinic at electrodes over depression Pain (PSS 0-10)
the University masseter (CES-D); Posttreatment:
of Pittsburgh. muscles; (2) depression 0.9 (95%
Case definition: computer- (POMS); CI, 1.3 to
pain and controlled credibility of 0.5)
tenderness of auditory tone treatment (0- 6 mo: 0.2 (95%
the muscles of and pulsating 10) CI, 0.3 to
mastication feedback; (3) 0.7)
and TMJ 5 min of no- Muscle
region and feedback palpation pain
limited resting (PPI):
mandibular baseline Posttreatment:
movements period with 1.5 (95%
Z2 mo jaw relaxed, CI, 2.2 to
(n = 80). 20 min of BF, 0.8)
and 5 min of 6 mo: 0.5 (95%
no-feedback. CI, 0.1 to
SM: (1) 1.1)
education on Depression
stress, (CES-D)
increased Posttreatment:
muscle 2.7 (95%
tension, and CI, 5.9 to
pain; (2) 0.5)
coping skills 6 mo: 2.7 (95%
training; (3) CI, 0.4 to
homework to 5.8)
practice Depression
relaxations (POMS):
skills and Posttreatment:
techniques. 2.3 (95%
(n = 30) CI, 5.4 to
IA: full-arch, flat 0.8)
heat-cured 6 mo: 4.4 (95%
acrylic resin CI, 1.3-7.5)
splint, worn at Credibility of
all times for treatment (0-
first 6 wk of 10)
treatment Posttreatment:
except during 0.5 (95% CI,
eating and oral 0.1-0.9)
hygiene.
Weekly
(Continued )
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.clinicalpain.com | 271
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Randhawa et al Clin J Pain Volume 32, Number 3, March 2016
TABLE 2. (continued)
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
meeting with
dentist for
instruction on
oral habits,
review and
adjustments of
IA use,
inspection for
irritation
(n = 30).
Turner and Patients (Z18 y) CBT by SCM Immediately Primary: pain Absence of
colleagues41,42 recruited from psychologists (education/ postinterven- intensity activity
the University (4 times/8 wk) attention tion, 3, 6, (GCPS); interference
of Washington and a manual control 12 mo activity (CBT vs.
Orofacial Pain (education condition) interference SCM):
Clinic between about TMD; provided by (GCPS). 12 mo: OR 4.2
June 2001 and psychological patient Jaw disability: (95% CI, 1.7-
February aspects of educators (4 masticatory 10.2)
2004. pain, times/8 wk). and Difference in
Case definition: relaxation, Manual: nonmastica- mean change
axis I TMD behavioural general health tory disability from baseline
diagnosis techniques for care (MFIQ). (CBT–SCM):
(RDC/TMD); pain information Depressive Pain intensity
facial pain management, (pain symptom 3 mo: 0.00 (95%
>3 mo; facial coping). medications; (BDI). CI, 0.38 to
pain-related Weekly personal communicat- Secondary: pain- 0.38)
disability rated TMD health ing with health related jaw use 6 mo: 0.80 (95%
as II high, III, care plan. care providers; limitations CI, 0.36-1.24)
or IV on the Progressive making (NRS 0-10); 12 mo: 0.80 (95%
GCPS relaxation and treatment pain beliefs CI, 0.331.27)
(n = 158). abdominal/ decisions); (SOPA); self- MFIQ
diaphragmatic information efficacy (TMD (nonmastica-
breathing on TMD, SES); pain tory):
techniques. TMD castrophizing 3 mo: 0.05 (95%
Relaxation treatments, (CSQ); CI, 0.01-0.09)
audiotape for TMD self- rumination 6 mo: 0.06 (95%
home practice. care, sessions (PCS); rest, CI, 0.02-0.10)
Discussion of reviewed main task 12 mo: 0.08 (95%
fear- points of persistence, CI, 0.05-0.12)
avoidance, manual coping self- MFIQ
identify and articles statements, (masticatory):
challenge (n = 79). relaxation 3 mo: 0.10 (95%
negative (CPCI). CI, 0.05-0.15)
thoughts in 6 mo: 0.10 (95%
response to CI, 0.05-0.15)
pain; relapse 12 mo: 0.14 (95%
prevention, CI, 0.09-0.19)
ways to Depression:
maintain gains 3 mo: 2.2 (95%
and deal with CI, 0.30-4.10)
setbacks 6 mo: 1.9 (95%
(n = 79). CI, 0.10-3.70)
Both groups 12 mo: 3.1 (95%
received usual CI, 1.26-4.94)
treatment: jaw Jaw use
posture limitation:
monitoring Postintervention:
and 0.06w
correction; Pain beliefs:
advice heat/ Disability:
cold to facial 3 mo: 0.40 (95%
areas; diet CI, 0.23-0.57)
modification; 6 mo: 0.60 (95%
(Continued )
272 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Clin J Pain Volume 32, Number 3, March 2016 Effectiveness of Noninvasive Interventions for TMD
TABLE 2. (continued)
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
medication; CI, 0.44-0.76)
jaw-stretching 12 mo: 0.40 (95%
exercises; CI, 0.23-0.57)
occlusal device Harm:
if indicated. 3 mo: 0.50 (95%
CI, 0.37-0.63)
6 mo: 0.50 (95%
CI, 0.37-0.63)
12 mo: 0.50 (95%
CI, 0.26-0.54)
Control:
3 mo: 0.60
(95% CI,
0.75 to 0.45)
6 mo: 0.70
(95% CI,
0.85 to
0.55)
12 mo: 0.30 (95%
CI, 0.14-0.46)
Self-efficacy:
3 mo: 1.30
(95% CI,
1.70 to
0.90)
6 mo: 1.30
(95% CI,
1.73 to
0.87)
12 mo: 1.50
(95% CI,
1.93 to
1.07)
Catastrophizing:
3 mo: 2.00 (95%
CI, 1.20-2.80)
6 mo: 1.20 (95%
CI, 0.40-2.00)
12 mo: 1.40 (95%
CI, 0.59-2.21)
Coping:
3 mo: 0.30
(95% CI,
0.65 to 0.50)
6 mo: 0.00 (95%
CI, 0.35 to
0.35)
12 mo: 0.10 (95%
CI, 0.26 to
0.46)
Relaxation:
3 mo: 1.30
(95% CI,
1.59 to
1.01)
6 mo: 0.90
(95% CI,
1.20 to
0.60)
12 mo: 0.80
(95% CI,
1.09 to
0.51)
(Continued )
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.clinicalpain.com | 273
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Randhawa et al Clin J Pain Volume 32, Number 3, March 2016
TABLE 2. (continued)
Patients and
Setting;
Number (n) Interventions; Comparisons;
References Enrolled No. Patients No. Patients Follow-up Outcomes Key Findings
Rest:
3 mo: 0.10
(95% CI,
0.45 to 0.25)
6 mo: 0.60
(95% CI,
0.96 to
0.24)
12 mo: 0.10
(95% CI,
0.46 to 0.26)
Depression:
BDI score <21
at 12 mo (CBT
vs. SCM):
OR = 3.8
(95% CI, 1.2-
12.0)
Proportions of
groups with
>50%
improvement
immediately
postinterven-
tion:
Significantly
more CBT
than
SCM
participants
reported
>50%
improvement
in daily
activity
interference
(34 vs. 13%
[P = 0.006])
and jaw use
limitations (29
vs. 10%
[P = 0.005]).
*Recalculated data from study.
wConfidence intervals could not be calculated.
BDI indicates Beck Depression Inventory; BF, biofeedback; CBT, cognitive behavioural therapy; CC, comprehensive care; EI, early intervention; EMG,
electromyography; GCPS, Graded Chronic Pain Scale; IA, intraoral appliance; IMT, intraoral myofascial therapy; IMTESC, intraoral myofascial therapy and
self-care exercises; MFIQ, Mandibular Function Impairment Questionnaire; MRI, magnetic resonance imaging; NAD, neck pain and associated disorders;
RCT, randomized controlled trial; RDC, research diagnostic criteria; ROM, range of motion; SC, self-care; SCL, Symptom Checklist; SCM, self-care
management; SM, stress management; TMD, temporomandibular disorder; TMJ, temporomandibular joint; UT, usual treatment; VAS, Visual Analog Scale.
clinically important improvement in pain and jaw opening occlusal device to a structured masticatory exercise pro-
compared with the wait list group. However, there were no gram does not provide added benefits compared with a
differences between intraoral myofascial therapy with structured masticatory muscle exercise program alone.39
structured education and TMD stretching compared with The trial by Niemela et al39 compared a multimodal inter-
intraoral myofascial therapy alone (Table 2). vention that combined an occlusal device and structured
exercises for the masticatory muscles to structured exercises
alone (Table 2). The participants were asked to wear the
TMD of Variable Duration
occlusal device regularly at night and were instructed to
Occlusal Device perform the exercises 2 to 3 times daily. There were no
Evidence from 2 RCTs suggests that occlusal devices statistically or clinically important differences between groups
are ineffective for the management of TMD of variable in terms of pain, active maximal opening, laterotrusion
duration.39,40 Evidence from 1 RCT suggests that adding an movements, protrusion movement, number of painful muscle
274 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Clin J Pain Volume 32, Number 3, March 2016 Effectiveness of Noninvasive Interventions for TMD
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.clinicalpain.com | 275
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Randhawa et al Clin J Pain Volume 32, Number 3, March 2016
that occlusal devices are effective in providing persistent are treated for TMD. Finally, we used condition-specific
pain and disability reduction in patients with TMD. MCIDs that were available in the literature. It is possible that
these MCIDs were computed from populations that differ
Comparison of Results to Previous Systematic from those reported in the RCTs included in our review and
Reviews may lack generalizability.
Liu et al25 previously reviewed the literature on the
effectiveness of CBT for TMD. However, they were unable
to determine the effectiveness of CBT. The difference in CONCLUSIONS
conclusions by Liu and colleagues and our review may be Our review suggests that patients with persistent TMD
due to the inclusion of different studies. Liu and colleagues may benefit from CBT, self-care management, or intraoral
included 2 small studies with a high risk of bias that were myofascial therapy. The current evidence does not support the
not designed to detect statistically signficant differences.55,56 use of occlusal device to reduce pain and disability in patients
Our results on the effectiveness of an occlusive device do with TMD. Other conservative interventions for the manage-
not support those of a recent meta-analysis.23 In their ment of TMD have not been supported by studies with a low
review, Ebrahim et al23 found “promising” evidence for the risk of bias. Moreover, economic evaluations to support
use of occlusal splints in reducing pain (but not in noninvasive interventions for TMD are needed.
improving quality of life and depression). These con-
clusions were based on a meta-analysis of 11 RCTs with ACKNOWLEDGMENTS
varying levels of methodological quality, heterogeneous
The authors acknowledge the invaluable contributions to
clinical conditions, and different control interventions.
this review from: Angela Verven, BA—Research Analyst,
State of the TMD Literature and Future Research UOIT-CMCC Centre for the Study of Disability Prevention
and Rehabilitation, University of Ontario Institute of
Directions
Technology (UOIT) and Canadian Memorial Chiropractic
The quality of evidence to guide the management of College (CMCC), Toronto, Ontario, Canada; Carlo
TMD is poor. Many studies identified in our search are Ammendolia, DC, PhD—University of Toronto, Toronto,
small and include important methodological limitations Ontario, Canada; David Cassidy, PhD, DrMedSc—
that limit their internal validity. Future studies need to University of South Denmark, University of Toronto, Tor-
follow accepted standards for trial designs and reporting of onto, Ontario, Canada; Doug Gross, BScPT, PhD—
results such as those found in CONSORT.57 Methodolog- University of Alberta, Edmonton, Alberta, Canada; Gail
ically robust studies are needed to evaluate the effectiveness Lindsay, RN, PhD—University of Ontario Institute of
of passive physical modalities, acupuncture, and manual Technology, Toronto, Ontario, Canada; John Stapleton,
therapies. Moreover, there is a need for more studies that MA—Open Policy Ontario, Toronto, Ontario, Canada;
evaluate the effectiveness of noninvasive interventions for Linda Carroll, PhD—University of Alberta, Edmonton,
the management of recent onset TMD (r3 mo). Finally, we Alberta, Canada; Margareta Nordin, Dr Med Sci, PT, CIE—
found no health economic evidence to inform the man- New York University, New York, New York, United States;
agement of TMD. Health economic evidence on the effi- Michel Lacerte, MDCM, MSc, FRCPC—University of
ciency (cost-effectiveness) of noninvasive interventions for Toronto, Toronto, Ontario, Canada; Mike Paulden, MA,
TMD in children and adults is a vital research priority. MSc—University of Alberta, Edmonton, Alberta, Canada;
Strengths and Limitations Murray Krahn, MD, MSc, FRCPC—University of Toronto,
Toronto, Ontario, Canada; Patrick Loisel, MD—University
Our study has strengths. First, we collaborated with a
of Toronto, University of Ontario Institute of Technology,
librarian to develop a sensitive search strategy that was
Toronto, Ontario, Canada; Poonam Cardoso, BHSc—UOIT-
methodologically rigorous. The search strategy was checked
CMCC Centre for the Study of Disability Prevention and
through peer-review to minimize errors. Second, we outlined
Rehabilitation, University of Ontario Institute of Technology
exhaustive inclusion and exclusion criteria to identify all rele-
(UOIT) and Canadian Memorial Chiropractic College
vant citations from the searched literature. Third, 2 inde-
(CMCC), Toronto, Ontario, Canada; Robert Brison, MD,
pendent reviewers conducted screening and critical appraisal to
MPH, FRCPC, CCFPC—Queen’s University, Kingston,
minimize error and bias. Fourth, we employed a well-accepted
Ontario, Canada; Shawn Marshall, MD, MSc, FRCPC—
and valid set of criteria (SIGN) for critical appraisal. Fifth, we
University of Ottawa, Ottawa, Ontario, Canada; HON.
used best-evidence synthesis to exclude studies with low
Roger Salhany, QC, BA, LLB—Retired Judge from the
internal validity to minimize bias in the reported results.
Ontario Superior Court of Justice, Canada. The authors also
Furthermore, we used a standardized methodology and all
thank Trish Johns-Wilson at the University of Ontario
reviewers undertook critical appraisal training. Sixth, we
Institute of Technology, Oshawa, ON, Canada for her review
searched the literature from 1990 onward in an effort to cap-
of the search strategy.
ture as many relevant studies as possible.
Our review also has limitations. First, we only included
REFERENCES
studies published in the English language and may have
excluded relevant non-English studies. However, previous 1. Bessa-Nogueira R, Vasconcelos B, Niederman R. The method-
systematic reviews have reported that the exclusion of non- ological quality of systematic reviews comparing temporoman-
English studies does not appear to bias results.58–61 Second, dibular joint disorder surgical and non-surgical treatment.
BMC Oral Health. 2008;8:27.
our search may have missed potentially relevant studies. 2. Di Fabio RP. Physical therapy for patients with TMD: a
However, the likelihood of this was small as we created a descriptive study of treatment, disability, and health status.
comprehensive and methodologically rigorous search strategy. J Orofac Pain. 1998;12:124–135.
Third, we limited our review to quantitative studies and 3. Canadian Dental Association. TMD (Temporomandibular
therefore did not capture the lived experience of patients who Joint Disorder). Available at http://www.cda-adc.ca/en/oral_
276 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Clin J Pain Volume 32, Number 3, March 2016 Effectiveness of Noninvasive Interventions for TMD
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.clinicalpain.com | 277
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
Randhawa et al Clin J Pain Volume 32, Number 3, March 2016
43. Slavin RE. Best evidence synthesis: an intelligent alternative to 53. Yuasa H, Kurita K. Treatment Group on Temporomandibular,
meta-analysis. J Clin Epidemiol. 1995;48:9–18. Disorders. Randomized clinical trial of primary treatment for
44. Viera AJ, Garrett JM. Understanding interobserver agreement: temporomandibular joint disk displacement without reduction
the kappa statistic. Fam Med. 2005;37:360–363. and without osseous changes: a combination of NSAIDs and
45. Abrams KR, Gillies CL, Lambert PC. Meta-analysis of mouth-opening exercise versus no treatment. Oral Surg Oral
heterogeneously reported trials assessing change from baseline. Med Oral Pathol Oral Radiol Endod. 2001;91:671–675.
Stat Med. 2005;24:3823–3844. 54. Oliveira-Campelo NM, Rubens-Rebelatto J, Marti N-Vallejo
46. Follmann D, Elliott P, Suh I, et al. Variance imputation for FJ, et al. The immediate effects of atlanto-occipital joint
overviews of clinical trials with continuous response. J Clin manipulation and suboccipital muscle inhibition technique on
Epidemiol. 1992;45:769–773. active mouth opening and pressure pain sensitivity over latent
47. Stauffer ME, Taylor SD, Watson DJ, et al. Definition of myofascial trigger points in the masticatory muscles. J Orthop
nonresponse to analgesic treatment of arthritic pain: an Sports Phys Ther. 2010;40:310–317.
analytical literature review of the smallest detectable difference, 55. Mishra KD, Gatchel RJ, Gardea MA. The relative efficacy of
the minimal detectable change, and the minimal clinically three cognitive-behavioral treatment approaches to tempor-
important difference on the pain visual analog scale. Int J omandibular disorders. J Behav Med. 2000;23:293–309.
Inflam. 2011;2011:231926. 56. Gardea MA, Gatchel RJ, Mishra KD. Long-term efficacy
48. Carroll LJ, Jones DC, Ozegovic D, et al. How well are you of biobehavioral treatment of temporomandibular disorders.
recovering? The association between a simple question about J Behav Med. 2001;24:341–359.
recovery and patient reports of pain intensity and pain 57. Schulz KF, Altman DG, Moher D. CONSORT 2010 State-
disability in whiplash-associated disorders. Disabil Rehabil. ment: updated guidelines for reporting parallel group
2012;34:45–52. randomised trials. BMJ. 2010;340:340.
49. Yuan J, Purepong N, Kerr DP, et al. Effectiveness of 58. Moher D, P B, Lawson ML, et al. The inclusion of reports of
acupuncture for low back pain: a systematic review. Spine. randomised trials published in languages other than English
2008;33:E887–E900. in systematic reviews. Health Technol Asses (Winchester,
50. Hiroe T, Kojima M, Yamamoto I, et al. Gradations of clinical England). 2003;7:1–90.
severity and sensitivity to change assessed with the Beck 59. Moher D, Fortin P, Jadad AR, et al. Completeness of
Depression Inventory-II in Japanese patients with depression. reporting of trials published in languages other than English:
Psychiatry Res. 2005;135:229–235. implications for conduct and reporting of systematic reviews.
51. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting Lancet. 1996;347:363–366.
items for systematic reviews and meta-analyses: the PRISMA 60. Morrison A, Polisena J, Husereau D, et al. The effect of
statement. BMJ. 2009;339:b2535. English-language restriction on systematic review-based meta-
52. Dworkin SF, Huggins KH, Wilson L, et al. A randomized analyses: a systematic review of empirical studies. Int J Technol
clinical trial using research diagnostic criteria for temporo- Asses Health Care. 2012;28:138–144.
mandibular disorders-axis II to target clinic cases for a tailored 61. Sutton AJ, Duval SJ, Tweedie RL, et al. Empirical assessment
self-care TMD treatment program. J Orofac Pain. 2002;16: of effect of publication bias on meta-analyses. BMJ. 2000;320:
48–63. 1574–1577.
278 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.